Updated data from India’s Covaxin’s final phase of trials shows that the vaccine can “neutralise” deadly mutations – including the double mutant. WION’s Palki Sharma tells you more. An interim analysis of the final phase data.
Covaxin, Bharat Biotech, Covid-19 vaccine, Covid19 Vaccine India